CanaFarma Hemp Products Corp. carries a market capitalization of 19,561.00, placing it among publicly traded companies globally. Its enterprise value stands at 235,096.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 19,561.00 |
| Enterprise Value | 235,096.00 |
CanaFarma Hemp Products Corp. currently has 195.61M shares outstanding.
| Shares Outstanding | 195.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CanaFarma Hemp Products Corp. maintains a current ratio of 0.33, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.33 |
| Quick Ratio | 0.01 |
| Debt / Equity | -38.35 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | -1,409.67 |
| Return on Assets (ROA) | -204.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.35 |
CanaFarma Hemp Products Corp.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CanaFarma Hemp Products Corp. generated -513,992.00 in revenue and converted that into -9.91M in net income, yielding earnings per share of -0.06. EBITDA reached -13.30M, while operating income came in at -13.53M.
| Revenue | -513,992.00 |
| Gross Profit | -5.27M |
| Operating Income | -13.53M |
| Pretax Income | -11.33M |
| Net Income | -9.91M |
| EBITDA | -13.30M |
| EBIT | -13.53M |
| Earnings Per Share (EPS) | -0.06 |
CanaFarma Hemp Products Corp. holds 9,171.00 in cash and equivalents against 244,267.00 in total debt, resulting in a net debt position of 235,096.00. Total book value stands at -1.49M, with working capital of -1.48M providing operational flexibility.
| Cash & Cash Equivalents | 9,171.00 |
| Total Debt | 244,267.00 |
| Net Debt | 235,096.00 |
| Equity (Book Value) | -1.49M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.48M |
CanaFarma Hemp Products Corp. produced -2.33M in operating cash flow over the past twelve months. After subtracting 403,832.00 in capital expenditures, free cash flow totaled -1.92M - equivalent to -0.01 per share.
| Operating Cash Flow | -2.33M |
| Capital Expenditures | 403,832.00 |
| Free Cash Flow | -1.92M |
| FCF Per Share | -0.01 |
CanaFarma Hemp Products Corp. operates with a gross margin of 1,026.25, reflecting its pricing power and cost economics. The operating margin of 2,633.12 and net profit margin of 1,928.78 provide insight into operational efficiency.
| Gross Margin | 1,026.25 |
| Operating Margin | 2,633.12 |
| Pretax Margin | 2,205.06 |
| Profit Margin | 1,928.78 |
| EBITDA Margin | 2,586.62 |
CanaFarma Hemp Products Corp. posts an Altman Z-Score of -60.90, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -60.90 |